During the past decade, Prostata zentrum Nordwest conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Prostata zentrum Nordwest" are "Prostatic Neoplasms" (1 trials), "Receptors, Fibroblast Growth Factor" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Prostata zentrum Nordwest" in a lesser frequency.

Most popular intervention types in "Prostata zentrum Nordwest" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Androgen Deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials), "Archival Tumor Tissue Sample" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prostata zentrum Nordwest" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Prostata zentrum Nordwest". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Prostata zentrum Nordwest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prostata zentrum Nordwest, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".